Home / About us

A preclinical partner like no other

Your strategic scientific partner providing expert-led study design, implementation and delivery to close your translational gap.

Bridging the translational gap with confidence

We are the preclinical CRO providing expert-led study design that helps close the translational gap, enabling you to test disease directly rather than approximate it.

Our growing team brings together scientists, technical specialists and operational experts with deep experience in chronic disease and human tissue research.

Working in close partnership with drug developers worldwide, we generate the evidence needed for confident, high-stakes decisions, replacing inherited assumptions with the most human-relevant evidence, and giving high-potential assets the strongest possible path to patients.

Our mission 

To be the gold-standard partner to drug developers, bridging the translational gap with the most human-relevant evidence available.

Our leadership

With an expert-led team specializing in chronic diseases, we bring the scientific depth needed to de-risk your drug discovery and development.

Our commitment to quality

We maintain rigorous quality standards across every stage, delivering consistent and reproducible data fit for confident decision-making.

ESG

Embedding environmental responsibility, ethical practice and strong governance across our operations, we align our work with the highest standards expected across modern drug development.

Make your next decision with confidence

Find out how studying your compound in viable human tissue changes what you can claim and what you can decide.

Precision analytics for complex pathophysiology

Our platform sets the standard in human-relevant evidence, giving drug developers a more definitive basis for evaluating asset performance in complex human disease and de-risking the pathway to patients.

Tissue bioreactor technology

Proprietary bioreactor systems designed to preserve native tissue structure and function, enabling controlled, extended study in living human tissue.

Tissue types and indications

Ethical procurement of viable human liver, lung and kidney tissue through established clinical partnerships for use in our PCTS platforms.

Reliably sourced. Incomparably real

Our solutions are grounded in established clinical partnerships that ensure the ethical procurement of human tissue.

This gives you access to the biologically relevant material needed to evaluate drug performance in a setting that reflects real human disease, strengthening the evidence behind your next decision.

The evidence your program demands

Speak to our team about your programme.